December 30, 2021 | Bayer, COVID, Data, Impetus Digital, Natalie Yeadon, Pharma, Tom Hsu, coronavirus, effects of covid, lessons learned
Tom Hsu, VP of Specialty Medicine at Bayer Canada, talks about how he got to where he is today and his experience working for Bayer in China and how that compares to the work he is doing now in Canada. He also discusses the lessons learned from the COVID-19 pandemic as well as his views on disruptive digital technologies in healthcare.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Jon Sockell, Co-founder and COO of Limbix, sits down with us in this Fireside Chat. See how Limbix is paving the way for prescription digital therapeutics and learn from their trials,…
In this session, we discussed systems change, wicked problems, and multisolving. We reviewed the transformational changes that can evolve and go beyond “cause and effect” thinking. In this dialogue, we…
Find out how Impetus Digital helped virtualize their client’s internal brand planning session
Eddie Power, Vice President of North America Medical Affairs, Hospital Business at Pfizer, discusses a range of topics, including the effects of COVID-19 on the way Medical Affairs teams work and…
Ladana Edwards, Partner at Deloitte Central Europe and Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as virtual…
A holistic view of how to work with patients virtually
Craig Lipset, Founder and Advisor at Clinical Innovation Partners and former Head of Clinical Innovation and Venture Partner at Pfizer, discusses everything from his personal health journey to his professional accomplishments,…
